AorTech International PLC Change of Adviser (8948W)

TIDMAOR

RNS Number : 8948W

AorTech International PLC

20 November 2017

20 November 2017

AorTech International plc

("AorTech" or the "Company")

Change of adviser

AorTech International plc (AIM: AOR), the biomaterials and medical device IP company, announces the appointment of Stockdale Securities Limited as its Nominated Adviser and Broker with immediate effect.

For further information contact:

AorTech International plc Tel: [phone]

Bill Brown, Chairman

Stockdale Securities Limited Tel: [phone]

Tom Griffiths/El-Hanan Lee

About AorTech:

AorTech has developed biostable, implantable polymers, including Elast-Eon(TM) and ECSil(TM) the world's leading long-term implantable co-polymers, now manufactured on their behalf by Biomerics LLC in Utah, USA. With several million implants and seven years of successful clinical use, AorTech polymers are being developed and used in cardiology and urological applications, including pacing leads, cardiac cannulae, stents and neuro stimulation devices. Devices manufactured from AorTech polymers have numerous US FDA PMA approvals, 510ks, CE Marks, Australian TGA and Japanese Ministry of Health approvals.

Elast-Eon(TM) and ECSil(TM)'s biostability is comparable to silicone while exhibiting excellent mechanical, blood contacting and flex-fatigue properties. These polymers can be processed using conventional thermoplastic extrusion and moulding techniques. A range of materials in a variety of application-specific formulations for use in medical devices and components are available.

This information is provided by RNS

The company news service from the London Stock Exchange

END

APPLLFLDLRLDLID

(END) Dow Jones Newswires

November 20, 2017 02:01 ET (07:01 GMT)